Modulation of LDL particle size after an oral glucose load is associated with insulin levels

Clinica Chimica Acta

Volumn 276, Issue 2, 1998, Pages 143-155

  Okumura, Kenji ^a   Matsui, Hideo ^a   Kawakami, Kei ^a   Morishima, Itsuro ^a   Numaguchi, Yasushi ^a   Murase, Kichiro ^a   Toki, Yukio ^a   Ito, Takayuki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoproteins; Glucose load; Insulin; LDL particle size; Stepwise regression analysis; Triglycerides

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PARTICLE SIZE; POSTPRANDIAL STATE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADULT; AGED; BLOOD PRESSURE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GLUCOSE TOLERANCE TEST; GLYCOPROTEINS; HUMANS; INSULIN; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; POSTPRANDIAL PERIOD;

EID: 0031670704     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00108-9     Document Type: Article

References (40)

1. Study Group, European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 1987;8:77-88.
2. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36-69.
3. Castelli WP, Carrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. J Am Med Assoc. 256:1986;2835-2838.
4. Krauss RM, Burke DJ Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 23:1984;97-104.
5. Coresh J, Kwiterovich PO Jr., Smith HH, Bachorick PS Associations of plasma triglyceride concentrations and LDL particle diameter, density and composition with premature coronary artery disease in men and women. J Lipid Res. 34:1993;1687-1697.
6. Campos H, Genest J, Blijlevens Eet al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 12:1992;187-195.
7. Swinkels DW, Demacker P, Hendricks J, Brenninkmeijier BJ, Stuyt P The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors. Atherosclerosis. 77:1989;59-67.
8. Crouse JR, Parks JS, Schey HM, Kahl FR Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 26:1985;566-574.
9. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc. 260:1988;1917-1921.
10. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 43:1988;838-846.
11. Austin MA, Brunzell JD, Fitch WL, Krauss RM Inheritance of low density lipoprotein subclass pattern in familial combined hyperlipidemia. Arteriosclerosis. 10:1990;520-530.
12. Austin MA, King MC, Vranian KM, Krauss RM Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
13. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV Greater effect of diabetes on LDL size in women than in men. Diabetes Care. 17:1994;1164-1171.
14. Singh ATK, Rainwater DL, Haffner SMet al. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol. 15:1995;1805-1811.
15. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 92:1993;141-146.
16. Selby JV, Austin MA, Newman Bet al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 88:1993;381-387.
17. Katzel LI, Coon PJ, Rogus E, Krauss RM, Goldberg AP Persistence of low HDL-C levels after weight reduction in older with small LDL particles. Arterioscler Thromb Vasc Biol. 15:1995;299-305.
18. Evans GF, Bensch WR, Apelgren LDet al. Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution. J Lipid Res. 35:1994;1634-1645.
19. Dinchuk J, Hart J, Gonzalez G, Karmann G, Schmidt D, Wirak DO Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein. Biochim Biophys Acta. 1255:1995;301-310.
20. Lagrost L, Gambert P, Lallemant C Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb. 14:1994;1327-1336.
21. Pacy PJH, Mitropoulos KA, Venkatesan S, Watts GF, Reeves BEA, Halliday D Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase. Atherosclerosis. 103:1993;231-243.
22. Miesenböck G, Hölzl B, Föger B, Brandstätter E, Paulweber B, Sandhofer F, Patsch JR Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 91:1993;448-455.
23. Bagdade JD, Dunn FL, Eckel RH, Ritter MC Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Arterioscler Thromb. 14:1994;1933-1939.
24. Garfinkel AS, Nilsson-Ehle P, Schotz MC Regulation of lipoprotein lipase induction by insulin. Biochim Biophys Acta. 424:1976;264-273.
25. Farese RV, Yost TJ, Eckel RH Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight human. Metabolism. 40:1991;214-216.
26. Sasaki T, Tanemura K, Kubota N Evaluation of the serum lipoprotein fraction values estimated by the turbidimetric method. Rinsho Byori. 25:1977;931-934.
27. Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
28. Okumura K, Kikuchi M, Matsui Het al. Abnormal arachidonate distribution in low-density lipoprotein and thoracic aorta in hyperinsulinemia. Metabolism. 44:1995;806-811.
29. 1C, and fructosamine on diabetes screening. Diabetes Care 1991;14:1075-7.
30. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL, Alberts JJ, Marcovina SM Measurement of apolipoprotein A-I and B during the National Health and Nutrition Examination Survey (NHANES) III. Clin Chem. 40:1994;1915-1920.
31. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
32. McNamara JR, Campos H, Ordovas JM, Perterson J, Wilson PDF, Schaefer EF Effect of gender, age, and lipid status on low-density lipoprotein subfraction distribution: results from the Framingham offspring study. Arteriosclerosis. 7:1987;483-490.
33. Campos H, Blijlevens E, McNamara JRet al. LDL particle size distribution: results from the Framingham offspring study. Arterioscler Thromb. 12:1992;1410-1419.
34. Beard CM, Barnard RJ, Robbins DC, Ordovas JM, Schaefer EJ Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation. Arterioscler Thromb Vasc Biol. 16:1996;201-207.
35. Katzel LI, Krauss RM, Goldberg AP Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. Arterioscler Thromb. 14:1994;1121-1128.
36. Ricci MS, Castaldi D, Samueli R, Boghich O Preliminary considerations on blood lipid parameters and blood insulin after oral glucose tolerance test. Quad Sclavo Diagn. 22:1986;58-67.
37. Hughes TA, Elam MB, Applegate WBet al. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease. Metabolism. 44:1995;1082-1098.
38. Haffner SM, Stern MP, Dunn JF, Mobley M, Blackwell J, Bergman RN Diminished insulin sensitivity and increased insulin response in non-obese, non-diabetic Mexican Americans. Metabolism. 39:1990;842-847.
39. Ferrannini E, Haffner SM, Mitchell BD, Stern MP Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:1991;416-422.
40. DeFronzo RA, Ferrannini E Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1994;173-194.